Lexapro antidepressant birth defects

Lexapro is in a class of drugs known as SSRI. Lexapro is in the pregnancy Category C. Most drugs fall into this category. Animal reproduction studies have shown an adverse effect on the fetus; there are no studies in humans, and the benefits from the use of Lexapro in pregnant women may be acceptable despite potential risks…acceptable to whom?

There are no studies in pregnant women nor as it is ethical to have pregnant women in studies which may harm the fetus.

If there are safer alternatives on the market, why would doctors prescribe Lexapro which is potentially dangerous to the fetus or newborn?

Do You Have a SSRI Birth Defects Case? »

According to the Lexapro labeling: Pregnancy-Nonteratogenic Effects provides information regarding complications developed by neonates exposed to Lexapro and other SSRIs or SNRIs (serotonin and norepinephrine reuptake inhibitors), late in the 3rd trimester.

Infants exposed to SSRIs in late pregnancy may have an increased risk for persistent pulmonary hypertension of the newborn or PPHN.

When treating a pregnant woman with Lexapro during the 3rd trimester, consider potential risks and benefits. Labeling describes a prospective longitudinal study in which women who discontinued antidepressant medication during pregnancy were more likely to experience a relapse of major depression.

Has your baby suffered a life threatening condition because you were prescribed and took Lexapro antidepressant while pregnant?

Contact Our Lexapro Antidepressant Birth Defects Lawyers Today »

You do have legal options. Ask Monheit Law what your legal options are. You are not alone.